Announcements Trials
Browse Landscape

Status

Completed 11Unknown 5Terminated 4Recruiting 3Not yet recruiting 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Choledocholithiasis 1Cholangitis, Sclerosing 1Cholangiocarcinoma 1Biliary Fistula 1

Interventions

Drug Therapy 107Cisplatin 97Radiotherapy 89Carboplatin 87Bevacizumab 79Oxaliplatin 74tislelizumab 68Capecitabine 67Cyclophosphamide 65Gemcitabine 64toripalimab 61Paclitaxel 57Specimen Handling 55pembrolizumab 54sintilimab 53Surgical Procedures, Operative 52anlotinib 49Magnetic Resonance Spectroscopy 49Fluorouracil 49Immune Checkpoint Inhibitors 43Blood Specimen Collection 42130-nm albumin-bound paclitaxel 42Standard of Care 39camrelizumab 36fludarabine 35lenvatinib 34Leucovorin 34venetoclax 30Radiosurgery 30Immunotherapy 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × OTHER × Cholangiopancreatography, Endoscopic Retrograde × Clear all
NCT06670547 2024-11-01

Spanish Registry of Quality Indicators and Adverse Events of Endoscopic Retrograde Cholangiopancreatography

Germans Trias i Pujol Hospital

Not yet recruiting
3,000 enrolled
Gastrointestinal

Biliary Fistula, Cholangitis, Sclerosing, Cholangiocarcinoma, Choledocholithiasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡